tiprankstipranks
Advertisement
Advertisement

AU:AGN Stock Latest News

WHO Confirms International Generic Name for Argenica’s Lead Stroke Drug
Company AnnouncementsWHO Confirms International Generic Name for Argenica’s Lead Stroke Drug
12d ago
AGN
Argenica Options Lapse Clarifies Capital Structure
PremiumCompany Announcements
Argenica Options Lapse Clarifies Capital Structure
13d ago
AGN
Argenica Advances ARG-007 Stroke Program and Strengthens Funding for Phase 2b Trial
PremiumCompany Announcements
Argenica Advances ARG-007 Stroke Program and Strengthens Funding for Phase 2b Trial
2M ago
AGN
Argenica boosts cash reserves with $3.97m R&D rebate to advance stroke drug
PremiumCompany Announcements
Argenica boosts cash reserves with $3.97m R&D rebate to advance stroke drug
3M ago
AGN
Argenica Widens Half-Year Loss as ARG-007 Stroke Trial Spending Climbs
PremiumCompany Announcements
Argenica Widens Half-Year Loss as ARG-007 Stroke Trial Spending Climbs
4M ago
AGN
Argenica Wins EMA Paediatric Waiver, Streamlining EU Pathway for Stroke Drug ARG-007
PremiumCompany AnnouncementsArgenica Wins EMA Paediatric Waiver, Streamlining EU Pathway for Stroke Drug ARG-007
5M ago
AGN
Argenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
Premium
Company Announcements
Argenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
5M ago
AGN
Argenica Therapeutics Announces Departure of Director Di Angus
Premium
Company Announcements
Argenica Therapeutics Announces Departure of Director Di Angus
6M ago
AGN
Argenica Chair Steps Down as Biotech Prepares for Next Growth Phase
PremiumCompany Announcements
Argenica Chair Steps Down as Biotech Prepares for Next Growth Phase
6M ago
AGN
Argenica’s ARG-007 Shows Promising Results in Severe Stroke Patients
PremiumCompany Announcements
Argenica’s ARG-007 Shows Promising Results in Severe Stroke Patients
6M ago
AGN
Argenica’s ARG-007 Shows Promising Results in Preclinical Stroke Study
PremiumCompany Announcements
Argenica’s ARG-007 Shows Promising Results in Preclinical Stroke Study
7M ago
AGN
Argenica Therapeutics AGM Resolutions Passed Successfully
PremiumCompany Announcements
Argenica Therapeutics AGM Resolutions Passed Successfully
7M ago
AGN
Argenica Therapeutics Advances ARG-007 Amidst Clinical and Market Challenges
PremiumCompany AnnouncementsArgenica Therapeutics Advances ARG-007 Amidst Clinical and Market Challenges
7M ago
AGN
Argenica Therapeutics Announces Retirement of Key Board Member
Premium
Company Announcements
Argenica Therapeutics Announces Retirement of Key Board Member
7M ago
AGN
Argenica Therapeutics Advances Stroke Treatment with Promising Trial Results
Premium
Company Announcements
Argenica Therapeutics Advances Stroke Treatment with Promising Trial Results
8M ago
AGN
Argenica Therapeutics Issues New Equity Securities as Part of Employee Incentive Scheme
PremiumCompany Announcements
Argenica Therapeutics Issues New Equity Securities as Part of Employee Incentive Scheme
8M ago
AGN
Argenica Therapeutics Reports Positive Phase 2 Trial Results for Stroke Treatment
PremiumCompany Announcements
Argenica Therapeutics Reports Positive Phase 2 Trial Results for Stroke Treatment
8M ago
AGN
Argenica Therapeutics Announces Details for Upcoming Annual General Meeting
PremiumCompany Announcements
Argenica Therapeutics Announces Details for Upcoming Annual General Meeting
8M ago
AGN
Argenica Therapeutics Unveils Strategic Presentation at ASX Conference
PremiumCompany Announcements
Argenica Therapeutics Unveils Strategic Presentation at ASX Conference
9M ago
AGN
Argenica Therapeutics Sets Date for Annual General Meeting
PremiumCompany AnnouncementsArgenica Therapeutics Sets Date for Annual General Meeting
9M ago
AGN
Argenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial Results
Premium
Company Announcements
Argenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial Results
10M ago
AGN
Argenica Therapeutics Unveils Phase 2 Trial Results
Premium
Company Announcements
Argenica Therapeutics Unveils Phase 2 Trial Results
10M ago
AGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >